NEW DRUG STRATEGIES IN CARDIOVASCULAR DISEASES

dc.contributor.authorDilfuza Ne'matovna Izzatulayeva
dc.date.accessioned2025-12-31T15:41:45Z
dc.date.issued2025-12-13
dc.description.abstractCardiovascular diseases (CVDs) remain one of the leading causes of mortality worldwide, demanding continuous innovation in therapeutic approaches. Recent advancements in molecular biology, pharmacogenomics, and biotechnology have contributed to the development of more effective and targeted drug strategies. These include personalized medicine, gene-based therapies, novel antithrombotic agents, antiinflammatory drugs, and compounds that improve endothelial function. Modern drug development also emphasizes reducing adverse effects and improving long-term patient outcomes. This paper highlights emerging pharmacological strategies aimed at preventing, managing, and treating cardiovascular diseases through innovative, evidence-based approaches
dc.formatapplication/pdf
dc.identifier.urihttps://scholarexpress.net/index.php/wbph/article/view/5715
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/50089
dc.language.isoeng
dc.publisherScholar Express Journals
dc.relationhttps://scholarexpress.net/index.php/wbph/article/view/5715/4836
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourceWorld Bulletin of Public Health; Vol. 53 (2025): WBPH; 13-15
dc.source2749-3644
dc.subjectCardiovascular diseases
dc.subjectnew drug strategies
dc.subjectpersonalized medicine
dc.titleNEW DRUG STRATEGIES IN CARDIOVASCULAR DISEASES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
izzatulayeva_2025_new_drug_strategies_in_cardiovascular_di.pdf
item.page.filesection.size
164.08 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections